Search Browse Earnings

ProMIS Neurosciences Inc.

Nasdaq:PMN

Pharmaceutical Preparations·TORONTO, A6

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ProMIS Neurosciences Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$14.3M

FY 2024

Net Income

-$13.2M

FY 2024

EPS (Diluted)

-$1.07

FY 2024

Stock Price

$16.97

-14.9%

2026-03-16

52W Range

$6.27 – $39.75

P/E Ratio

-15.9x

Market Cap

$913.2M

Cash

$12.6M

FY 2024

Total Debt

—

Net Cash

$12.6M

FY 2023

Enterprise Value

$900.6M

Debt / EBITDA

0.9x

FY 2024

EV / EBITDA

-63.1x

Employees

—

CEO

Warma Neil K